Elliott v. A.H. Robins Co.

262 A.D.2d 132, 691 N.Y.S.2d 501, 1999 N.Y. App. Div. LEXIS 6753
CourtAppellate Division of the Supreme Court of the State of New York
DecidedJune 15, 1999
StatusPublished
Cited by9 cases

This text of 262 A.D.2d 132 (Elliott v. A.H. Robins Co.) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Elliott v. A.H. Robins Co., 262 A.D.2d 132, 691 N.Y.S.2d 501, 1999 N.Y. App. Div. LEXIS 6753 (N.Y. Ct. App. 1999).

Opinion

—Appeals from orders (13 papers), Supreme Court, New York County (Helen Freedman, J.), entered on or about October 19, 1998, which granted the pharmacy defendants’ motions to dismiss the complaint as against them for failure to state a cause of action and denied plaintiffs’ cross motions to exempt them from the same court’s Case Management Orders, deemed to be from the ensuing judgment, same court and Justice, entered November 2, 1998, dismissing the complaint as against the pharmacy defendants, and as so considered, the judgment is unanimously affirmed, without costs.

The court properly exercised its discretion in issuing the Case Management Orders to “centralize”, rather than consolidate, the approximately 250 diet drug cases assigned to it by the Chief Administrative Judge. We note that although plaintiffs, in their cross motion, sought to be exempted from such orders, their counsel requested coordination of discovery in the litigation, did not object in any material respect to the substance of any of the orders at issue nor did plaintiffs appeal from any of the original orders. In any event, contrary to their current contentions, the Case Management Orders protected plaintiffs’ rights to act individually and to object to any order. The record also belies plaintiffs’ claims that discovery was improperly stayed in this matter.

Since there is no allegation that the pharmacy defendants failed to fill the prescriptions precisely as they were directed by the manufacturers and physicians, and plaintiffs do not allege [133]*133that they had a condition of which the pharmacists were aware, rendering prescription of the drugs at issue contraindicated, there is no basis to hold the pharmacists liable under theories of negligence, breach of warranty or strict liability, and the complaint against the pharmacists was properly dismissed (Bichler v Willing, 58 AD2d 331; and see, Negrin v Alza Corp., 1999 WL 144507, 1999 US Dist LEXIS 3006 [SD NY, Mar. 17, 1999, Batts, J.]; Ullman v Grant, 114 Misc 2d 220; cf., Hand v Krakowski, 89 AD2d 650). Concur — Rosenberger, J. P., Tom, Rubin, Saxe and Buckley, JJ.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Abrams v. Bute
138 A.D.3d 179 (Appellate Division of the Supreme Court of New York, 2016)
BURTON, BONNIE L. v. SCIANO, M.D., MICHAEL T.
110 A.D.3d 1435 (Appellate Division of the Supreme Court of New York, 2013)
Brumaghim v. Eckel
94 A.D.3d 1391 (Appellate Division of the Supreme Court of New York, 2012)
Winters v. Alza Corp.
690 F. Supp. 2d 350 (S.D. New York, 2010)
Downing v. Hyland Pharmacy
2008 UT 65 (Utah Supreme Court, 2008)
Fagan v. AmerisourceBergen Corp.
356 F. Supp. 2d 198 (E.D. New York, 2004)
Madison v. American Home Products Corp.
595 S.E.2d 493 (Supreme Court of South Carolina, 2004)
Schaerrer v. Stewart's Plaza Pharmacy, Inc.
2003 UT 43 (Utah Supreme Court, 2003)
In Re Rezulin Products Liability Litigation
133 F. Supp. 2d 272 (S.D. New York, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
262 A.D.2d 132, 691 N.Y.S.2d 501, 1999 N.Y. App. Div. LEXIS 6753, Counsel Stack Legal Research, https://law.counselstack.com/opinion/elliott-v-ah-robins-co-nyappdiv-1999.